ATE433575T1 - Neurotransmission-störungen - Google Patents
Neurotransmission-störungenInfo
- Publication number
- ATE433575T1 ATE433575T1 AT01940736T AT01940736T ATE433575T1 AT E433575 T1 ATE433575 T1 AT E433575T1 AT 01940736 T AT01940736 T AT 01940736T AT 01940736 T AT01940736 T AT 01940736T AT E433575 T1 ATE433575 T1 AT E433575T1
- Authority
- AT
- Austria
- Prior art keywords
- neurotransmission
- bodily fluid
- developmental disorders
- mammal
- musk
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/71—Assays involving receptors, cell surface antigens or cell surface determinants for growth factors; for growth regulators
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0014878.3A GB0014878D0 (en) | 2000-06-16 | 2000-06-16 | Neurotransmission disorders |
PCT/GB2001/002661 WO2001096601A2 (en) | 2000-06-16 | 2001-06-15 | Neurotransmission disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE433575T1 true ATE433575T1 (de) | 2009-06-15 |
Family
ID=9893880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01940736T ATE433575T1 (de) | 2000-06-16 | 2001-06-15 | Neurotransmission-störungen |
Country Status (9)
Country | Link |
---|---|
US (2) | US7267820B2 (de) |
EP (1) | EP1327147B1 (de) |
AT (1) | ATE433575T1 (de) |
AU (1) | AU2001274239A1 (de) |
CA (1) | CA2455271C (de) |
DE (1) | DE60138958D1 (de) |
ES (1) | ES2327100T3 (de) |
GB (1) | GB0014878D0 (de) |
WO (1) | WO2001096601A2 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0014878D0 (en) * | 2000-06-16 | 2000-08-09 | Isis Innovation | Neurotransmission disorders |
CA2778478C (en) | 2009-10-21 | 2018-06-19 | Georgia Health Sciences University Research Institute, Inc. | Detection and treatment of lrp4-associated neurotransmission disorders |
GR1007341B (el) | 2010-04-21 | 2011-07-05 | ΕΛΛΗΝΙΚΟ ΙΝΣΤΙΤΟΥΤΟ ΠΑΣΤΕΡ (κατά ποσοστό 40%), | Διαγνωστικος προσδιορισμος |
JP6240919B2 (ja) * | 2014-04-03 | 2017-12-06 | 地方独立行政法人東京都健康長寿医療センター | 加齢または筋萎縮の診断用バイオマーカー |
US10093743B2 (en) * | 2014-11-18 | 2018-10-09 | Premkumar Christadoss | Muscle specific tyrosine kinase-fluorophore conjugate compositions, kits and methods of using |
WO2020055241A1 (en) | 2018-09-10 | 2020-03-19 | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) | Musk activation |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5814478A (en) * | 1995-12-15 | 1998-09-29 | Regeneron Pharmaceuticals, Inc. | Tyrosine kinase receptors and ligands |
US6342220B1 (en) | 1997-08-25 | 2002-01-29 | Genentech, Inc. | Agonist antibodies |
GB0014878D0 (en) * | 2000-06-16 | 2000-08-09 | Isis Innovation | Neurotransmission disorders |
-
2000
- 2000-06-16 GB GBGB0014878.3A patent/GB0014878D0/en not_active Ceased
-
2001
- 2001-06-15 AU AU2001274239A patent/AU2001274239A1/en not_active Abandoned
- 2001-06-15 CA CA2455271A patent/CA2455271C/en not_active Expired - Lifetime
- 2001-06-15 EP EP01940736A patent/EP1327147B1/de not_active Expired - Lifetime
- 2001-06-15 ES ES01940736T patent/ES2327100T3/es not_active Expired - Lifetime
- 2001-06-15 DE DE60138958T patent/DE60138958D1/de not_active Expired - Lifetime
- 2001-06-15 AT AT01940736T patent/ATE433575T1/de not_active IP Right Cessation
- 2001-06-15 US US10/311,575 patent/US7267820B2/en not_active Expired - Lifetime
- 2001-06-15 WO PCT/GB2001/002661 patent/WO2001096601A2/en active Application Filing
-
2007
- 2007-08-27 US US11/895,793 patent/US7732147B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO2001096601A2 (en) | 2001-12-20 |
GB0014878D0 (en) | 2000-08-09 |
US7732147B2 (en) | 2010-06-08 |
US20080057524A1 (en) | 2008-03-06 |
CA2455271C (en) | 2012-10-16 |
WO2001096601A3 (en) | 2002-03-28 |
ES2327100T3 (es) | 2009-10-26 |
EP1327147B1 (de) | 2009-06-10 |
AU2001274239A1 (en) | 2001-12-24 |
US7267820B2 (en) | 2007-09-11 |
CA2455271A1 (en) | 2001-12-20 |
DE60138958D1 (de) | 2009-07-23 |
EP1327147A2 (de) | 2003-07-16 |
US20040082010A1 (en) | 2004-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0410261B8 (pt) | anticorpo monoclonal que se liga especificamente ao probnp, métodos para detecção específica de probnp in vitro e para diagnóstico de insuficiência cardíaca in vitro, kit para medição de probnp, e linhagem celular de hibridoma mab 1.21.3 | |
DK0914155T3 (da) | Monoklonale antistoffer, der er spepcifikke for det ekstracellulære domæne af prostataspecifikt membran-antigen | |
DE60335022D1 (de) | Internalisierende Antikörper spezifisch für das RAAG10 Zelloberflächenziel | |
DK0540573T3 (da) | Assay for frit- og kompleksbundet prostataspecifikt antigen (PSA) | |
SE9502196D0 (sv) | Ultrasensitive immunoassays | |
RU2005131842A (ru) | Моноклональное антитело и продуцирующая его гибридома | |
NZ288235A (en) | Monoclonal antibody directed against the receptor tyrosine kinase flt4 and use in diagnosis and therapy | |
ATE487946T1 (de) | Analytischer sandwichtest zur bestimmung von nt- probnp | |
NZ330475A (en) | Antibodies, and use thereof in measuring lipid peroxidation in biological samples and method for inducing inflammation | |
BR0113213A (pt) | Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo | |
RU2017114626A (ru) | Антитело, связывающее линейный эпитоп человеческого р53, и его применение в диагностике | |
ATE433575T1 (de) | Neurotransmission-störungen | |
DE50011181D1 (de) | Nachweis des pyruvatkinase-isoenzyms im stuhl | |
EP1476757A4 (de) | Verfahren und kit zur krebsvorhersage | |
ATE282830T1 (de) | Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz | |
EP1245957A3 (de) | Methode zur Konzentrationsbestimmung von Ceruloplasmin in einem Blutflecken mittels enzymgekoppeltem Immunosorbent-Assay oder mittels dissoziationsverstärktem, zeitaufgelöstem Immunofluoreszenzassay, sowie Kit zum Auffinden der Wilson-Krankheit und Diagnosemethode für letztere | |
SE0202702D0 (sv) | Immunoassays for specific determination of SCCA isoforms | |
CA2346406A1 (en) | Detection of pleiotrophin | |
SE0100595D0 (sv) | Immunological detection of prostate diseases and prostatic-related diseases | |
KR870002453A (ko) | 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법 | |
DE50304756D1 (de) | Verfaren zur diagnose von neoplasmen | |
EP0364971A3 (de) | Verfahren zum Nachweis der Legionella-Antigene in Körperflüssigkeiten und dergleichen und eine Testzusammensetzung zur Durchführung des Verfahrens | |
FI20011517A0 (fi) | Menetelmä alkoholinkulutuksen osoittamiseksi, menetelmässä käytettäviä välineitä sekä niiden valmistus | |
ATE290694T1 (de) | Diagnose von autoimmun-nebennierenkrankheit | |
IT1317355B1 (it) | Anticorpi policlonali. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |